PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

An open-label, PhaseⅢ study to evaluate the efficacy and safety of MRA in patients with RA

Phase 3

Chugai Pharmaceutical